Accretion Pharmaceuticals H1 FY27 Net Profit Surges 70.8% YoY to ₹8.2 Crore
Accretion Pharmaceuticals reports H1 FY27 net profit of ₹8.2 crore, a 70.8% YoY increase, with operating margins expanding to 19.6% on ₹55.0 crore revenue.
ALFA News
Straight from the exchange filing
Accretion Pharmaceuticals reports H1 FY27 net profit of ₹8.2 crore, a 70.8% YoY increase, with operating margins expanding to 19.6% on ₹55.0 crore revenue.